About Erythropoietin injection
Renocel 10000 Erythropoietin Injection is an in-demand, praiseworthy solution recommended for anemia associated with chronic renal failure or cancer chemotherapy. Manufactured by Intas Biopharmaceuticals, this affordable, resplendent product showcases a triumphant record in patient care. Formulated as a clear, colorless liquid, each pre-filled syringe contains 10,000 IU of Erythropoietin Alfa. Backed by IP regulatory approval, Renocel 10000 demands a prescription and is suitable for both adults and children when administered intravenously or subcutaneously under strict medical supervision. Storage is vital-keep between 2C and 8C. Always check batch and expiry details.
Erythropoietin Injection: Usage and Key Features
Intended for patients with anemia due to chronic renal failure or cancer chemotherapy, this highly recommended biological injection is administered via intravenous or subcutaneous routes. Packaged as a convenient pre-filled syringe, its clear liquid form ensures ease of use. Administer only as directed by a physician, under strict medical supervision. The precision delivery system and stringent regulatory compliance make it suitable for adults and children, providing reliable, effective stimulation of red blood cell production.
Export Market, Delivery and FOB Port for Erythropoietin Injection
Renocel 10000 enjoys notable expenditure in export markets, reinforcing its market value in regions requiring dependable anemia management. Exported from India, primary FOB ports include Mumbai and Ahmedabad. The main export markets comprise Asia, Africa, and the Middle East. Delivery times are prompt, generally spanning 1-2 weeks, reflecting efficient supply chains and significant market penetration. This ensures international buyers can reliably receive this essential medication with minimal delay, optimizing healthcare investments globally.
FAQ's of Erythropoietin injection:
Q: How is Erythropoietin injection administered?
A: Erythropoietin injection is administered either intravenously or subcutaneously, typically by a healthcare professional under strict medical supervision.
Q: What is the main benefit of using Renocel 10000?
A: The primary benefit of Renocel 10000 is its effectiveness in stimulating the production of red blood cells, making it valuable in treating anemia due to chronic renal failure or chemotherapy.
Q: When should Erythropoietin injection not be used?
A: This injection should not be used in patients with uncontrolled hypertension or those with known hypersensitivity to Erythropoietin or formulation ingredients.
Q: Where should Renocel 10000 be stored?
A: Renocel 10000 should be stored in a refrigerator at 2C to 8C. It is essential not to freeze the product for safety and efficacy.
Q: What are the usage guidelines for this product?
A: Dosage and administration must always follow a physician's direction. The usual dosage is 10,000 IU/1.0 ml, provided as a pre-filled syringe for single use.
Q: How does the process of erythropoiesis benefit patients?
A: The process of erythropoiesis, stimulated by this injection, increases red blood cell production, thereby improving oxygen delivery in patients suffering from anemia.